skip navigation, go to content
Neuroprotection Exploratory Trials in Parkinson's Disease: NET-PD National Institute of Neurological Disorders and Stroke logo
National Institutes of Health
NET-PD Home
[What is the NET-PD Study?]
[Who is sponsoring NET-PD?]
[What drugs are being studied?]
[Where can I participate?]
[Am I eligible?]
[FAQs]
[Study publications]
[Privacy and confidentiality]
[En EspaƱol]
[For more information, call toll free 1-800-352-9424 email  info@parkinsontrial.org or visit clinicaltrials.gov.] info@partkinsontrial.org clinicaltrials.gov Learn more about NET-PD clinical trials for Parkinson's Disease
[Am I eligible?]

You may be eligible to participate in this study if:

  • You are willing and able to give informed consent and comply with study requirements.
  • You have been diagnosed with PD within the last 5 years.
  • You are receiving medications to treat your PD for 2 years or less (the study staff will review your medications to determine if you are eligible).

You may not be eligible to participate if:

  • You have used creatine within the 2 weeks before entering the study.
  • You have participated in another drug trial within the month before the start date of the NET-PD study.
  • You have a known sensitivity to creatine.
  • The study team does not feel that it would be safe for you to participate due to your overall medical condition.
  • The study team is not confident that you have a diagnosis of PD.



NET-PD Home | What is the NET-PD Study? | Who is sponsoring NET-PD? | What drugs are being studied?
Where can I participate? | Am I eligible? | FAQs | Study publications | Privacy and confidentiality | NINDS Home

U.S. Department of Health and Human Services logo     National Institutes of Health logo     National Institute of Neurological Disorders and Stroke logo     USA.gov logo